ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,877 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselSwedish Orphan Biovitrum AG
Swedish Orphan Biovitrum AG Logo
Verified· 2 sources

Swedish Orphan Biovitrum AG

Summary

About the company

The company develops and distributes innovative treatments for rare diseases, particularly in the field of hematology, such as hemophilia and immune thrombocytopenia (ITP). The focus is on improving the lives of patients through access to new therapies and promoting patient-centricity and engagement.

AI-generated
Offering

Products & services

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Industry:
Pharmaceutical Industry
✓ Offered8
Medicines
Medicines for the treatment and prevention of rare diseases, including haemophilia A and B, PNH, ITP, HLH, CAPS, FMF, HT-1, FCS and DLBCL.
Therapeutic areas
Haematology, immunology and specialty care, with focus on haemophilia, immune thrombocytopenia, paroxysmal nocturnal haemoglobinuria, rare genetic and metabolic diseases.
Access programmes
Managed access and emergency access to Sobi medicines for patients with serious or life-threatening rare diseases when alternatives or market access are limited.
Managed Access Programmes
Access to investigational medicines for eligible patients when no satisfactory alternatives exist and clinical trial enrolment is not possible, subject to local laws and review.
Clinical Trials
Patient-centred clinical trials and clinical research designed with patient input, transparent communication and inclusion in Sobi’s development programmes.

Knowledge

No knowledge articles yet

Once Swedish Orphan Biovitrum AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Swedish Orphan Biovitrum AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Swedish Orphan Biovitrum AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Swedish Orphan Biovitrum AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Riehenring 182
4058 Basel
Opening hours
Mon
08:00 - 17:00
Tue
08:00 - 17:00
Wed
08:00 - 17:00
Thu
08:00 - 17:00
Fri
08:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-284.917.678
Founded
2014 · 12 years
Last commercial register change
October 15, 2025
Employees
101 to 500

Similar companies

CA
Celonic AG
Basel
RC
Roche Chemische Unternehmungen AG
Basel
CP
Corden Pharma International Switzerland GmbH
Basel
MP
Mepha Pharma AG
Basel